Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine

被引:125
|
作者
Malherbe, P
Kratochwil, N
Zenner, MT
Piussi, J
Diener, C
Kratzeisen, C
Fischer, C
Porter, RHP
机构
[1] F Hoffmann La Roche & Co Ltd, PRBN D, Pharma Div, Discovery Res CNS, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche & Co Ltd, Chem, CH-4070 Basel, Switzerland
关键词
D O I
10.1124/mol.64.4.823
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabotropic glutamate (mGlu) 5 is a G-protein-coupled metabotropic glutamate receptor that plays an important role as a modulator of synaptic plasticity, ion channel activity, and excitotoxicity. 2-Methyl-6-(phenylethynyl)-pyridine ( MPEP) is a highly potent, noncompetitive, selective, and systemically active antagonist of mGlu5 receptors. It binds to a novel allosteric site that resides within the seven-transmembrane domain of mGlu5 receptors. Using site-directed mutagenesis, [H-3]MPEP binding, a functional Ca2+ mobilization assay, and rhodopsin-based homology modeling, we identified eight residues (Pro-654(3.36), Tyr-658(3.40), Leu-743(5.47), Thr-780(6.44), Trp-784(6.48), Phe-787(6.51), Tyr-791(6.55), and Ala-809(7.47)) that are crucial for MPEP-binding to rat mGlu5 receptors. Four mutations, Y658(3.40)V, W784(6.48)A, F787(6.51)A, and A809(7.47)V, caused complete loss of [ 3H] MPEP binding and also blocked the MPEP-mediated inhibition of quisqualate-induced intracellular Ca2+ mobilization. To visualize these experimental findings, we have constructed a homology model based on the X-ray crystal of bovine rhodopsin and have suggested a possible binding mode of MPEP. We propose that MPEP via its interactions with a network of the aromatic residues including Phe-658(3.40) in transmembrane (TM) 3 helix and Trp-798(6.48), Phe-787(6.51), and Tyr-791(6.55) in TM6 helix prevents the movement of TM6 helix relative to TM3 helix, a step that is required for receptor activation, and consequently stabilizes the inactive conformation of mGlu5 receptor. In the TM6 region, we observed a striking similarity between the critical residues involved in MPEP-binding site with those of previously identified as 1-ethyl-2-methyl-6-oxo-4-(1,2,4,5-tetrahydro-benzo[d]azepin-3-yl)-1,6-dihydropyrimidine-5-carbonitrile-binding pocket of mGlu1, pointing to a common mechanism of inhibition shared by both antagonists.
引用
收藏
页码:823 / 832
页数:10
相关论文
共 50 条
  • [1] Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents
    Spooren, WPJM
    Vassout, A
    Neijt, HC
    Kuhn, R
    Gasparini, F
    Roux, S
    Porsolt, RD
    Gentsch, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1267 - 1275
  • [2] The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats
    Schulz, B
    Fendt, M
    Gasparini, F
    Lingenhöhl, K
    Kuhn, R
    Koch, M
    NEUROPHARMACOLOGY, 2001, 41 (01) : 1 - 7
  • [3] Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding
    Butkiewicz, Mariusz
    Rodriguez, Alice L.
    Rainey, Shane E.
    Wieling, Joshua
    Luscombe, Vincent B.
    Stauffer, Shaun R.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    Meiler, Jens
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (08): : 3427 - 3436
  • [4] 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain
    Luis Albasanz, Jose
    Santana, Soraya
    Guzman-Sanchez, Fernando
    Leon, David
    Burgos, Javier S.
    Martin, Mairena
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (12): : 1690 - 1697
  • [5] Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: Comparison with dizocilpine
    Lee, B
    Platt, DM
    Rowlett, JK
    Adewale, AS
    Spealman, RD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 1232 - 1240
  • [6] In vivo evidence that the metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) acts as an inhibitor of the norepinephrine transporter
    Heidbreder, C
    Bianchi, M
    Lacroix, L
    Crespi, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U104 - U104
  • [7] Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine, in rat models of inflammatory pain
    Bowes, M
    Panesar, M
    Gentry, C
    Urban, L
    Gasparini, F
    Kuhn, R
    Walker, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U130 - U130
  • [8] Effect of metabotropic glutamate receptor subtype 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine on mechanosensory afferents innervating rat hind paw following inflammation
    Su, X
    Urban, MO
    NEUROSCIENCE LETTERS, 2005, 390 (03) : 123 - 128
  • [9] The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
    Montana, Michael C.
    Cavallone, Laura F.
    Stubbert, Kristi K.
    Stefanescu, Andrei D.
    Kharasch, Evan D.
    Gereau, Robert W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03): : 834 - 843
  • [10] METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONIST 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE PRODUCES ANTIDEPRESSANT EFFECTS IN RATS: ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR
    Liu, C. Y.
    Jiang, X. X.
    Zhu, Y. H.
    Wei, D. N.
    NEUROSCIENCE, 2012, 223 : 219 - 224